THC BioMed Announces Line of Credit

VANCOUVER , May 29, 2019 /CNW/ – THC BioMed Intl Ltd. (“THC” or the “Company”) (THC.CN) announces that it has entered into a line of credit with President, CEO and director John Miller for up to $500,000 (the “Line of Credit”). Each separate draw down of funds from the Line of Credit (“Draw Down Amount”) will not bear interest for the first three calendar months following its withdrawal. The Interest will be calculated and payable monthly, on the last business day of each month until the Line of Credit is repaid in full.